Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00495079
Status:
COMPLETED
Last Update Posted:
2021-03-05
First Post:
2007-06-28
Brief Title:
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Sponsor:
Spectrum Pharmaceuticals Inc
Organization:
Spectrum Pharmaceuticals Inc
Organization Data
Organization:
Spectrum Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
HBS407
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spectrum Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Parexel | INDUSTRY |